Your browser doesn't support javascript.
Sex and gender differences in chronic kidney disease and access to care around the globe.
García, Guillermo García; Iyengar, Arpana; Kaze, François; Kierans, Ciara; Padilla-Altamira, Cesar; Luyckx, Valerie A.
  • García GG; Nephrology Service, Hospital Civil de Guadalajara "Fray Antonio Alcalde," University of Guadalajara Health Sciences Center (Centro Universitario de Ciencias de la Salud), Guadalajara, Jalisco, Mexico.
  • Iyengar A; Department of Paediatric Nephrology, St. John's National Academy of Health Sciences, Bangalore, India.
  • Kaze F; Faculty of Medicine and Biomedical Sciences, Yaoundé University Teaching Hospital, Yaoundé, Cameroon.
  • Kierans C; Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, United Kingdom.
  • Padilla-Altamira C; Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, United Kingdom; Center for Research and Higher Studies in Social Anthropology, Guadalajara, Jalisco, Mexico.
  • Luyckx VA; Department of Nephrology, University Children's Hospital University of Zurich, Zurich, Switzerland,; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa. Electronic address: Val
Semin Nephrol ; 42(2): 101-113, 2022 03.
Article in English | MEDLINE | ID: covidwho-1867762
ABSTRACT
The difference between sex, the biological construct, and gender, the social construct, may be most evident in settings of vulnerability. Globally, chronic kidney disease is more prevalent among women, but the prevalence of end-stage kidney failure, and especially receipt of kidney replacement therapy, is higher in men. These differences likely reflect a combination of physiological and social/structural risk factors that independently modulate kidney disease and/or its progression. The distribution of the most common risk factors such as hypertension and obesity differ between men and women and may impact disease risk differentially. Social and structural gender-related inequities remain stark across the globe. More women live in poverty, receive less education, and are more dependent on others for health care decision making, but men may have a higher risk of injury, occupational exposures, and less access to screening, prevention, and primary care. In this article, we explore how social determinants of health affect kidney disease risk and access to care differentially across genders, and differently across the globe. We also describe specific challenges experienced by boys and girls with kidney disease, how culture and geography may impact kidney care in places where resources are particularly limited such as sub-Saharan Africa, and give examples of social and structural circumstances that place young men and women at high risk of kidney disease in Mexico and Central America, illustrated by case vignettes. The coronavirus disease-2019 pandemic has raised awareness of pervasive gender-based inequities within all societies. This applies to kidney disease and is not new. The nephrology community must add its voice to the calls for action, for a more just society overall, and for the recognition of the roles of sex and gender as modulators of kidney disease risk and access to care.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renal Insufficiency, Chronic / COVID-19 / Kidney Failure, Chronic Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Language: English Journal: Semin Nephrol Year: 2022 Document Type: Article Affiliation country: J.semnephrol.2022.04.001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Renal Insufficiency, Chronic / COVID-19 / Kidney Failure, Chronic Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Language: English Journal: Semin Nephrol Year: 2022 Document Type: Article Affiliation country: J.semnephrol.2022.04.001